SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015366
Filing Date
2024-06-04
Accepted
2024-06-04 16:30:18
Documents
2
Period of Report
2024-06-01

Document Format Files

Seq Description Document Type Size
1 form4-06042024_040614.html 4  
1 form4-06042024_040614.xml 4 5517
2 ex24-06042024_040615.htm EX-24 6370
  Complete submission text file 0001415889-24-015366.txt   13339
Mailing Address 701 LEE ROAD SUITE 103 WAYNE PA 19087
Business Address 701 LEE ROAD SUITE 103 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Issuer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ACLARIS THERAPEUTICS, INC. 701 LEE ROAD, SUITE 103 WAYNE PA 19087
Business Address
Molineaux Christopher P. (Reporting) CIK: 0001654773 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37581 | Film No.: 241018599